Pierre Legault

Insider Reports History

Entity
Individual
Location
P.O. Box 1028, C/O Stone Management Llc, Berwyne, PA
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pierre Legault:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Director Common Stock 65K $1.19M $18.27 Feb 7, 2024 Direct
BICYCLE THERAPEUTICS plc Director Ordinary Shares 33.5K $586K $17.50 Jan 2, 2024 Direct
BICYCLE THERAPEUTICS plc Director Stock Option (right to buy) 24K Jan 2, 2024 Direct

Insider Reports Filed by Pierre Legault

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc Feb 7, 2024 1 $0 4 Feb 9, 2024 Director
BCYC BICYCLE THERAPEUTICS plc Jan 2, 2024 2 $0 4 Jan 4, 2024 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $0 4 Feb 3, 2023 Director
SNDX Syndax Pharmaceuticals Inc Jan 12, 2023 9 -$616K 4 Jan 13, 2023 Director
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2023 2 $0 4 Jan 5, 2023 Director
SNDX Syndax Pharmaceuticals Inc Aug 5, 2022 6 -$331K 4 Aug 9, 2022 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $0 4 Feb 3, 2022 Director
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2022 2 $0 4 Jan 5, 2022 Director
BCYC BICYCLE THERAPEUTICS plc Dec 20, 2021 9 -$7.38M 4 Dec 22, 2021 Director
SNDX Syndax Pharmaceuticals Inc Dec 20, 2021 6 -$618K 4 Dec 22, 2021 Director